Management of NSAID-Induced Angioedema

Immediate Management

• Patients with oropharyngeal or laryngeal involvement should be observed in a medical facility capable of performing immediate intubation or emergency cricothyroidotomy, and monitored closely for signs of impending airway closure, according to the Journal of Allergy and Clinical Immunology 1
• The American Academy of Allergy, Asthma, and Immunology recommends considering elective intubation if any signs of airway compromise develop, as this can progress to life-threatening laryngeal edema, although the provided reference is not directly from them but from the Journal of Allergy and Clinical Immunology 1

Long-Term Management

• The guideline society Praxis Medical Insights recommends permanently discontinuing meloxicam and documenting this as a drug allergy prominently in the medical record 2
• Patients who have reacted to multiple NSAIDs are at particularly high risk and should avoid the entire NSAID class, with the strength of evidence for this recommendation not explicitly stated but implied through clinical insights from Praxis Medical Insights 2, 3

Critical Pitfalls to Avoid

• The Journal of Allergy and Clinical Immunology advises against delaying airway management, as waiting for pharmacologic interventions to work can be fatal in cases with laryngeal involvement 1
• It is crucial to distinguish NSAID-induced angioedema from ACE inhibitor-induced angioedema, as the latter is bradykinin-mediated and may respond to icatibant, whereas NSAID angioedema follows a different pathway, as noted in the Journal of Allergy and Clinical Immunology 4